From Wikipedia, the free encyclopedia
A Norepinephrine-dopamine reuptake inhibitor is a class of drugs that is both:
An example is Bupropion.[1]
| Antidepressants (ATC N06A) edit |
| Monoamine oxidase inhibitors (MAOI) |
Harmaline, Iproclozide, Iproniazid, Isocarboxazid, Nialamide, Phenelzine, Selegiline, Toloxatone, Tranylcypromine |
| Reversible inhibitor of monoamine oxidase A (RIMA) |
Brofaromine, Moclobemide |
| Dopamine reuptake inhibitor (DARI) |
Amineptine, Phenmetrazine, Vanoxerine, Modafinil |
| Norepinephrine-dopamine reuptake inhibitors |
Bupropion |
| Norepinephrine reuptake inhibitor (NRI) or (NARI) |
Atomoxetine, Maprotiline, Reboxetine, Viloxazine |
| Serotonin-norepinephrine reuptake inhibitor (SNRI) |
Duloxetine, Milnacipran, Venlafaxine |
| Selective serotonin reuptake inhibitor (SSRI) |
Alaproclate, Etoperidone, Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Zimelidine |
| Selective serotonin reuptake enhancer (SSRE) |
Tianeptine |
| Tricyclic antidepressants (TCA) |
Amitriptyline, Amoxapine, Butriptyline, Clomipramine, Desipramine, Dibenzepin, Dothiepin, Doxepin, Imipramine, Iprindole, Lofepramine, Melitracen, Nortriptyline, Opipramol, Protriptyline, Trimipramine |
| Tetracyclic antidepressants |
Maprotiline, Mianserin, Nefazodone, Trazodone |
| Noradrenergic and specific serotonergic antidepressant (NaSSA) Mirtazapine |
[edit] References
- ^ Stephen M. Stahl, M.D., Ph.D.; et al (2004). "A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor" (pdf). Journal of Clinical Psychiatry; 6(04) 159-166 2004 PHYSICIANS POSTGRADUATE PRESS, INC. Retrieved on 2006-09-02.
